Protein tyrosine phosphatase 1B (PTP1B), as a therapeutic target for the treatment of Type-II diabetes and obesity, has been the subject of intense study over the past decade [1,2,3,4,5]. This evidence concerns the gene PTPN1 and type 2 diabetes mellitus.